LENSAR reports Q1 revenue of $8.3M, net loss $4.3M; ALLY installed base grows to 19 systems with backlog of 13

LENSAR, Inc.

2023-Q1 EPS reported -$0.40 revenue$8,252,000

Revenue $8.3M, down 12% YoY; net loss $4.3M ($0.40/sh) vs $6.7M loss in Q1 2022.
ALLY installed base increased to 19 systems; backlog of 13 additional systems as of May 12.
U.S. procedure volumes up 13% YoY; LLS users who upgraded to ALLY performed >20% more procedures Q1 2023 vs Q1 2022.
Company raised $20M private placement; management expects 2023 ALLY installs to exceed 30.
Worldwide procedures 31,600 (down from 38,901 due to South Korea); R&D expenses down 66% to $1.7M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LENSAR, Inc. reported the quarter ended March 31, 2023 results: revenue $8.3 million, net income $4.3 million, EPS ($0.40) per share.

Period: the quarter ended March 31, 2023
Revenue: $8.3 million
Net income: $4.3 million
EPS: ($0.40) per share
Result: reported results

Exact text from the filing

Total revenue for the quarter ended March 31, 2023 was $8.3 million, a decrease of $1.1 million, or 12%, compared to total revenue of $9.3 million for the quarter ended March 31, 2022.

View on SEC.gov

Browse all earnings releases →

LENSAR, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-021945

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.